Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

Dual H1 and CysLT1 antagonist reported by Dutch and Japanese researchers

June 4, 1997

Preclinical and clinical data support use of cerebrocrast as neuroprotectant

June 4, 1997

ACE inhibitors inhibit bone resorption in vitro

June 3, 1997

Proarrhythmia associated with cisapride; exacerbation by cytochrome P-450 inhibitors

June 3, 1997

Comparative studies reported for treatment of paroxysmal atrial fibrillation

June 3, 1997

Mechanism of antiarrhythmic effect of UK-14304

June 2, 1997

Clinical electrophysiological and hemodynamic effects of BRL-32872A

June 2, 1997

New i.v. formulation of amiodarone better tolerated in patients

June 2, 1997

New NSAID under development in Russia

June 2, 1997

Anti-LFA-1 MAbs for transplantation

June 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.